Next Article in Journal
Intensive Postural and Motor Activity Program Reduces Scoliosis Progression in People with Rett Syndrome
Next Article in Special Issue
The Rapid Implementation of Ad Hoc Tele-Critical Care Respiratory Therapy (eRT) Service in the Wake of the COVID-19 Surge
Previous Article in Journal
Ventilation-Induced Lung Injury (VILI) in Neonates: Evidence-Based Concepts and Lung-Protective Strategies
Previous Article in Special Issue
Does Preoperative Cognitive Optimization Improve Postoperative Outcomes in the Elderly?
Review

Considerations for Cannabinoids in Perioperative Care by Anesthesiologists

1
Department of Anesthesiology and Critical Care, University of Pennsylvania, Philadelphia, PA 19104, USA
2
School of Osteopathic Medicine, Campbell University, Buies Creek, NC 27506, USA
*
Authors to whom correspondence should be addressed.
Academic Editor: Patrice Forget
J. Clin. Med. 2022, 11(3), 558; https://doi.org/10.3390/jcm11030558
Received: 20 December 2021 / Revised: 17 January 2022 / Accepted: 18 January 2022 / Published: 22 January 2022
(This article belongs to the Collection Delivery of Anesthesia: Pre-operative and Post-operative)
Increased usage of recreational and medically indicated cannabinoid compounds has been an undeniable reality for anesthesiologists in recent years. These compounds’ complicated pharmacology, composition, and biological effects result in challenging issues for anesthesiologists during different phases of perioperative care. Here, we review the existing formulation of cannabinoids and their biological activity to put them into the context of the anesthesia plan execution. Perioperative considerations should include a way to gauge the patient’s intake of cannabinoids, the ability to gain consent properly, and vigilance to the increased risk of pulmonary and airway problems. Intraoperative management in individuals with cannabinoid use is complicated by the effects cannabinoids have on general anesthetics and depth of anesthesia monitoring while simultaneously increasing the potential occurrence of intraoperative hemodynamic instability. Postoperative planning should involve higher vigilance to the risk of postoperative strokes and acute coronary syndromes. However, most of the data are not up to date, rending definite conclusions on the importance of perioperative cannabinoid intake on anesthesia management difficult. View Full-Text
Keywords: cannabinoids; anesthesia; cannabidiol; tetrahydrocannabinol; neocannabinoids; perioperative management; review; human cannabinoids; anesthesia; cannabidiol; tetrahydrocannabinol; neocannabinoids; perioperative management; review; human
Show Figures

Figure 1

MDPI and ACS Style

Laudanski, K.; Wain, J. Considerations for Cannabinoids in Perioperative Care by Anesthesiologists. J. Clin. Med. 2022, 11, 558. https://doi.org/10.3390/jcm11030558

AMA Style

Laudanski K, Wain J. Considerations for Cannabinoids in Perioperative Care by Anesthesiologists. Journal of Clinical Medicine. 2022; 11(3):558. https://doi.org/10.3390/jcm11030558

Chicago/Turabian Style

Laudanski, Krzysztof, and Justin Wain. 2022. "Considerations for Cannabinoids in Perioperative Care by Anesthesiologists" Journal of Clinical Medicine 11, no. 3: 558. https://doi.org/10.3390/jcm11030558

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop